Literature DB >> 22027145

Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells.

Jean-Pierre Raufman1, Kunrong Cheng, Neeraj Saxena, Ahmed Chahdi, Angelica Belo, Sandeep Khurana, Guofeng Xie.   

Abstract

Mammalian matrix metalloproteinases (MMPs) which degrade extracellular matrix facilitate colon cancer cell invasion into the bloodstream and extra-colonic tissues; in particular, MMP1 expression correlates strongly with advanced colon cancer stage, hematogenous metastasis and poor prognosis. Likewise, muscarinic receptor signaling plays an important role in colon cancer; muscarinic receptors are over-expressed in colon cancer compared to normal colon epithelial cells. Muscarinic receptor activation stimulates proliferation, migration and invasion of human colon cancer cells. In mouse intestinal neoplasia models genetic ablation of muscarinic receptors attenuates carcinogenesis. In the present work, we sought to link these observations by showing that MMP1 expression and activation plays a mechanistic role in muscarinic receptor agonist-induced colon cancer cell invasion. We show that acetylcholine, which robustly increases MMP1 expression, stimulates invasion of HT29 and H508 human colon cancer cells into human umbilical vein endothelial cell monolayers - this was abolished by pre-incubation with atropine, a non-selective muscarinic receptor inhibitor, and by pre-incubation with anti-MMP1 neutralizing antibody. Similar results were obtained using a Matrigel chamber assay and deoxycholyltaurine (DCT), an amidated dihydroxy bile acid associated with colon neoplasia in animal models and humans, and previously shown to interact functionally with muscarinic receptors. DCT treatment of human colon cancer cells resulted in time-dependent, 10-fold increased MMP1 expression, and DCT-induced cell invasion was also blocked by pre-treatment with anti-MMP1 antibody. This study contributes to understanding mechanisms underlying muscarinic receptor agonist-induced promotion of colon cancer and, more importantly, indicates that blocking MMP1 expression and activation has therapeutic promise to stop or retard colon cancer invasion and dissemination.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22027145      PMCID: PMC3221914          DOI: 10.1016/j.bbrc.2011.10.052

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Regulation of matrix metalloproteinase expression in tumor invasion.

Authors:  J Westermarck; V M Kähäri
Journal:  FASEB J       Date:  1999-05       Impact factor: 5.191

2.  Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats.

Authors:  T Narisawa; N E Magadia; J H Weisburger; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

3.  Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors.

Authors:  Kunrong Cheng; Jean-Pierre Raufman
Journal:  Biochem Pharmacol       Date:  2005-10-01       Impact factor: 5.858

4.  MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer.

Authors:  E Sunami; N Tsuno; T Osada; S Saito; J Kitayama; S Tomozawa; T Tsuruo; Y Shibata; T Muto; H Nagawa
Journal:  Oncologist       Date:  2000

5.  Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.

Authors:  E A Baker; F G Bergin; D J Leaper
Journal:  Br J Surg       Date:  2000-09       Impact factor: 6.939

6.  Deoxycholic acid promotes the growth of colonic aberrant crypt foci.

Authors:  Christopher Flynn; David C Montrose; Daniel L Swank; Masako Nakanishi; Jillian N M Ilsley; Daniel W Rosenberg
Journal:  Mol Carcinog       Date:  2007-01       Impact factor: 4.784

Review 7.  Role of matrix metalloproteinases (MMPs) in colorectal cancer.

Authors:  Stanley Zucker; Jeffrey Vacirca
Journal:  Cancer Metastasis Rev       Date:  2004 Jan-Jun       Impact factor: 9.264

8.  Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; W T Melvin; J E Fothergill
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

Review 9.  Activation of muscarinic receptor signaling by bile acids: physiological and medical implications.

Authors:  Jean-Pierre Raufman; Kunrong Cheng; Piotr Zimniak
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

10.  Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells.

Authors:  Kunrong Cheng; Piotr Zimniak; Jean-Pierre Raufman
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more
  31 in total

1.  Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.

Authors:  Anan H Said; Shien Hu; Ameer Abutaleb; Tonya Watkins; Kunrong Cheng; Ahmed Chahdi; Panjamurthy Kuppusamy; Neeraj Saxena; Guofeng Xie; Jean-Pierre Raufman
Journal:  Biochem J       Date:  2017-02-20       Impact factor: 3.857

Review 2.  Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.

Authors:  Jessica Felton; Shien Hu; Jean-Pierre Raufman
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

Review 3.  Nerves in gastrointestinal cancer: from mechanism to modulations.

Authors:  Nathalie Vaes; Musa Idris; Werend Boesmans; Maria M Alves; Veerle Melotte
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-02       Impact factor: 73.082

Review 4.  Bile acids are nutrient signaling hormones.

Authors:  Huiping Zhou; Phillip B Hylemon
Journal:  Steroids       Date:  2014-05-10       Impact factor: 2.668

5.  Bedside to bench: role of muscarinic receptor activation in ultrarapid growth of colorectal cancer in a patient with pheochromocytoma.

Authors:  Erik C von Rosenvinge; Kunrong Cheng; Cinthia B Drachenberg; Carol B Fowler; David L Evers; Guofeng Xie; Jean-Pierre Raufman
Journal:  Mayo Clin Proc       Date:  2013-10-04       Impact factor: 7.616

6.  Targeted Synthesis and Characterization of a Gene Cluster Encoding NAD(P)H-Dependent 3α-, 3β-, and 12α-Hydroxysteroid Dehydrogenases from Eggerthella CAG:298, a Gut Metagenomic Sequence.

Authors:  Sean M Mythen; Saravanan Devendran; Celia Méndez-García; Isaac Cann; Jason M Ridlon
Journal:  Appl Environ Microbiol       Date:  2018-03-19       Impact factor: 4.792

Review 7.  Role of the parasympathetic nervous system in cancer initiation and progression.

Authors:  M Tibensky; B Mravec
Journal:  Clin Transl Oncol       Date:  2020-08-08       Impact factor: 3.405

Review 8.  Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer.

Authors:  Alyssa Schledwitz; Guofeng Xie; Jean-Pierre Raufman
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

9.  Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.

Authors:  Zhongsheng Peng; Jean-Pierre Raufman; Guofeng Xie
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis.

Authors:  Zhongsheng Peng; Jonathon Heath; Cinthia Drachenberg; Jean-Pierre Raufman; Guofeng Xie
Journal:  BMC Cancer       Date:  2013-04-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.